翟致远
Lv4
490 积分
2021-06-17 加入
-
Absorption, Metabolism and Excretion of Surufatinib in Rats and Humans
2个月前
已完结
-
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer
3个月前
已完结
-
A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors
3个月前
已关闭
-
Korean Society of Thyroid Radiology Guidelines for the Management of Pediatric Thyroid Nodules: Suitability and Risk Factors
4个月前
已完结
-
2023 Update of the Korean Thyroid Association Guidelines for the Management of Thyroid Nodules
5个月前
已完结
-
Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database
5个月前
已完结
-
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2
5个月前
已完结
-
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
6个月前
已完结
-
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
6个月前
已完结
-
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
7个月前
已完结